VIP and PACAP inhibit Fas ligand-mediated bystander lysis by CD4(+) T cells.
Delgado, M
VIP and PACAP inhibit Fas ligand-mediated bystander lysis by CD4(+) T cells. [electronic resource] - Journal of neuroimmunology Jan 2001 - 78-88 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0165-5728
10.1016/s0165-5728(00)00414-8 doi
Animals
CD4-Positive T-Lymphocytes--drug effects
Cell Line
Cytotoxicity, Immunologic--drug effects
Fas Ligand Protein
Female
Membrane Glycoproteins--physiology
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Mice, Inbred DBA
Neuropeptides--pharmacology
Pituitary Adenylate Cyclase-Activating Polypeptide
Vasoactive Intestinal Peptide--pharmacology
fas Receptor--physiology
VIP and PACAP inhibit Fas ligand-mediated bystander lysis by CD4(+) T cells. [electronic resource] - Journal of neuroimmunology Jan 2001 - 78-88 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0165-5728
10.1016/s0165-5728(00)00414-8 doi
Animals
CD4-Positive T-Lymphocytes--drug effects
Cell Line
Cytotoxicity, Immunologic--drug effects
Fas Ligand Protein
Female
Membrane Glycoproteins--physiology
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Mice, Inbred DBA
Neuropeptides--pharmacology
Pituitary Adenylate Cyclase-Activating Polypeptide
Vasoactive Intestinal Peptide--pharmacology
fas Receptor--physiology